Search For "biotech"
COVID vaccine: Covaxin price reduced from Rs 1,200 to Rs 225 per dose for
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 9 (ANI): Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for
Read More
Covaxin supply suspension by WHO not to impact travel by people: MEA
Updated : 3 years, 11 months ago IST
New Delhi [India], April 8 (ANI): World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over "process and facility upgrade" requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs said o
Read More
Japan recognizes India's COVAXIN to facilitate travel between both countri
Updated : 3 years, 11 months ago IST
Tokyo [Japan], April 7 (ANI): Japan recognizes India's COVID-19 vaccine COVAXIN manufactured by Bharat Biotech with effect from April 10 to further facilitate travel from India to Japan, said the Indian Embassy in Japan on Thursday.
Read More
Israeli delegation meets Karnataka Minister, discusses IT, biotechnology
Updated : 3 years, 11 months ago IST
Bengaluru (Karnataka) [India], April 6 (ANI): The delegation of Israel's National Defense College met Karnataka Minister for Higher Education CN Ashwath Narayan on Wednesday.
Read More
Direct Biologics reveals successful outcomes from EXIT COVID-19 Phase II C
Updated : 3 years, 11 months ago IST
Austin [Texas], April 6 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle (EV) platform technology, announces topline results from its first-in-human, multicenter, Phase II double-blind, placeb
Read More
Bharat Biotech to rectify issues raised by WHO on Covaxin soon: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organization regarding its COVID-19 vaccine-- Covaxin-- in a few days and added that the company has informed about this development to the Drugs Con
Read More
WHO suspension for Covaxin supply only for UN agencies: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related to safety or efficacy issues but only to supply for United Nations agencies, sources said.
Read More
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO susp
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana)[India], April 3 (ANI): Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.
Read More
Bharat Biotech temporarily slows down COVAXIN production for facility opti
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 1 (ANI): Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.
Read More
Covaxin-maker Bharat Biotech MD D Krishna Ella, Joint MD Suchitra Ella con
Updated : 3 years, 11 months ago IST
New Delhi [India], March 28 (ANI): Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath Kovind on Monday.
Read More
Taylor & Francis Group partners with Biotech Research Society to Ampli
Updated : 3 years, 11 months ago IST
New Delhi [India], March 24 (ANI/BusinessWire India): Taylor & Francis Group is pleased to announce a publishing partnership with the Biotech Research Society, India (BRSI). Under the terms of the partnership, the BRSI will recommend prospective authors from its membership to Taylor &
Read More
Moderna requests FDA to authorize second COVID-19 booster shot for adults
Updated : 3 years, 12 months ago IST
Washington [US], March 18 (ANI/Xinhua): American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already recei
Read More